The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Proteomic analysis of aged and OPTN E50K retina in the development of normal tension glaucoma
Abstract
Progressive degeneration of retinal ganglion cells (RGCs) is a major characteristic of glaucoma, whose underlying mechanisms are still largely unknown. An E50K mutation in the Optineurin (OPTN) gene is a leading cause of normal tension glaucoma (NTG), directly affecting RGCs without high intraocular pressure and causing severe glaucomatous symptoms in clinical settings. A systematic analysis of the NTG mouse model is crucial for better understanding of the underlying pathological mechanisms for glaucoma. To elucidate proteomic and biochemical pathway alterations during NTG development, we established an OPTN E50K mutant mouse model through CRISPR/Cas9. Retinal proteins from resulting mice exhibiting glaucomatous phenotypes were subject to tandem mass tag-labeled quantitative proteomics and then analyzed through bioinformatics methods to characterize the molecular and functional signatures of NTG. We identified 6364 quantitative proteins in our proteomic analysis. Bioinformatics analysis revealed that OPTN E50K mice experienced protein synthesis dysregulation, age-dependent energy defects and autophagy-lysosome pathway dysfunction. Certain biological features, including amyloid deposition, RNA splicing, microglia activation and reduction of crystallin production, were similar to Alzheimer’s disease. Our study is the first to describe proteomic and biochemical pathway alterations in NTG pathogenesis during disease advancement. Several proteomic signatures overlapped with retinal changes found in the ad mice model, suggesting the presence of common mechanisms between age-related degenerative disorders, as well as prospective new targets for diagnostic and therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“consistent with previous findings that the E50K mutation decreased the overall abundance of OPTN protein in the mouse eye [40]”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310
Autophagic cell death: the story of a misnomer
Kroemer, G., & Levine, B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2529 · Cited by 1,453
Jonas, J. B., Aung, T., Bourne, R. R., Bron, A. M., Ritch, R., & Panda-Jonas, S. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31469-1 · Cited by 1,322
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Cunnane, S. C., Trushina, E., Morland, C., Prigione, A., Casadesus, G., Andrews, Z. B., Beal, M. F., Bergersen, L. H., Brinton, R. D., de la Monte, S., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0072-x · Cited by 1,003
Microglial Phagocytosis of Live Neurons
Brown, G. C., & Neher, J. J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3710 · Cited by 853
Koronyo-Hamaoui, M., Koronyo, Y., Ljubimov, A. V., Miller, C. A., Ko, M. K., Black, K. L., Schwartz, M., & Farkas, D. L. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.06.020 · Cited by 672
Vitamin B 3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice
Williams, P. A., Harder, J. M., Foxworth, N. E., Cochran, K. E., Philip, V. M., Porciatti, V., Smithies, O., & John, S. W. M. (2017) · Science · doi:10.1126/science.aal0092 · Cited by 617
The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma.
Ramirez, A. I., de Hoz, R., Salobrar-Garcia, E., Salazar, J. J., Rojas, B., Ajoy, D., López-Cuenca, I., Rojas, P., Triviño, A., & Ramírez, J. M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00214 · Cited by 466
Ribosome Dysfunction Is an Early Event in Alzheimer's Disease
Ding, Q., Markesbery, W. R., Chen, Q., Li, F., & Keller, J. N. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3040-05.2005 · Cited by 433
Luo, R., Su, L.-Y., Li, G., Yang, J., Liu, Q., Yang, L.-X., Zhang, D.-F., Zhou, H., Xu, M., Fan, Y., et al. (2020) · Autophagy · doi:10.1080/15548627.2019.1596488 · Cited by 364
Self-citationHsieh, Y.-C., Guo, C., Yalamanchili, H. K., Abreha, M., Al-Ouran, R., Li, Y., Dammer, E. B., Lah, J. J., Levey, A. I., Bennett, D. A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.104 · Cited by 196
Meier, S., Bell, M., Lyons, D. N., Rodriguez-Rivera, J., Ingram, A., Fontaine, S. N., Mechas, E., Chen, J., Wolozin, B., LeVine, H., et al. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3029-15.2016 · Cited by 190
Chi, Z.-L., Akahori, M., Obazawa, M., Minami, M., Noda, T., Nakaya, N., Tomarev, S., Kawase, K., Yamamoto, T., Noda, S., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq146 · Cited by 151
Feng, W., Zhang, Y., Wang, Z., Xu, H., Wu, T., Marshall, C., Gao, J., & Xiao, M. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00688-1 · Cited by 150
Serum autoantibodies to heat shock proteins in glaucoma patients from Japan and the United States
Wax, M. (2001) · Ophthalmology · doi:10.1016/s0161-6420(00)00525-x · Cited by 112
Glaucoma: Focus on mitochondria in relation to pathogenesis and neuroprotection
Osborne, N. N., Núñez-Álvarez, C., Joglar, B., & del Olmo-Aguado, S. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.04.032 · Cited by 101
Sayyad, Z., Sirohi, K., Radha, V., & Swarup, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-17241-0 · Cited by 96
Shah, S. Z. A., Zhao, D., Hussain, T., & Yang, L. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.09.004 · Cited by 55
Research works printed but not linked: 48
- Weinreb, 2014, The pathophysiology and treatment of glaucoma, a review, JAMA, 311, 1901, 10.1001/jama.2014.3192 · DOI · Paper page
- Iwase, 2004, The prevalence of primary open-angle glaucoma in Japanese, the Tajimi study, Ophthalmology, 111, 1641
- Song, 2011, Prevalence of glaucoma in a rural northern China adult population, a population-based survey in kailu county, Inner Mongolia, Ophthalmology, 118, 1982, 10.1016/j.ophtha.2011.02.050 · DOI
- Minegishi, 2016, Significance of optineurin mutations in glaucoma and other diseases, Prog. Retin. Eye Res., 55, 149, 10.1016/j.preteyeres.2016.08.002 · DOI
- Shim, 2018, Optineurin E50K triggers BDNF deficiency-mediated mitochondrial dysfunction in retinal photoreceptor cell line, Biochem. Biophs. Res. Commun., 503, 2690, 10.1016/j.bbrc.2018.08.025 · DOI
- Vander Wall, 2020, Retinal ganglion cells with a glaucoma OPTN (E50K) mutation exhibit neurodegenerative phenotypes when derived from three-dimensional retinal organoids, Stem Cell Rep., 15, 52, 10.1016/j.stemcr.2020.05.009 · DOI · Paper page
- Mancino, 2018, Glaucoma and Alzheimer disease, one age-related neurodegenerative disease of the brain, Curr. Neuropharmacol., 16, 971, 10.2174/1570159X16666171206144045 · DOI · Paper page
- Osawa, 2011, Optineurin in neurodegenerative diseases, Neuropathology, 31, 569, 10.1111/j.1440-1789.2011.01199.x · DOI · Paper page
- Thanos, 2014, Role of crystallins in ocular neuroprotection and axonal regeneration, Prog. Retin. Eye Res., 42, 145, 10.1016/j.preteyeres.2014.06.004 · DOI
- Fischer, 2008, Crystallins of the beta/gamma-superfamily mimic the effects of lens injury and promote axon regeneration, Mol. Cell. Neurosci., 37, 471, 10.1016/j.mcn.2007.11.002 · DOI
- Inagaki, 2018, Effect of Timolol on Optineurin aggregation in transformed induced pluripotent stem cells derived from patient with familial glaucoma, Invest. Ophthalmol. Vis. Sci., 59, 2293, 10.1167/iovs.17-22975 · DOI
- Mossmann, 2014, Amyloid-β peptide induces mitochondrial dysfunction by inhibition of preprotein maturation, Cell Metab., 20, 662, 10.1016/j.cmet.2014.07.024 · DOI · Paper page
- Munemasa, 2015, Autophagy in axonal degeneration in glaucomatous optic neuropathy, Prog. Retin. Eye Res., 47, 1, 10.1016/j.preteyeres.2015.03.002 · DOI
- Verkhratsky, 2014, Glia in the pathogenesis of neurodegenerative diseases, Biochem. Soc. Trans., 42, 1291, 10.1042/BST20140107 · DOI · Paper page
- Wei, 2019, Neuroinflammation and microglia in glaucoma, time for a paradigm shift, J. Neurosci. Res., 97, 70, 10.1002/jnr.24256 · DOI · Paper page
- Deng, 2019, Amyloid β induces early changes in the ribosomal machinery, cytoskeletal organization and oxidative phosphorylation in retinal photoreceptor cells, Front. Mol. Neurosci., 12, 24, 10.3389/fnmol.2019.00024 · DOI
- Mirzaei, 2017, Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes, Sci. Rep., 7, 10.1038/s41598-017-12858-7 · DOI
- Mirzaei, 2019, Upregulation of proteolytic pathways and altered protein biosynthesis underlie retinal pathology in a mouse model of Alzheimer's disease, Mol. Neurobiol., 56, 6017, 10.1007/s12035-019-1479-4 · DOI
- Tseng, 2015, Visual impairment in an optineurin mouse model of primary open-angle glaucoma, Neurobiol. Aging, 36, 2201, 10.1016/j.neurobiolaging.2015.02.012 · DOI · Paper page
- Zhang, 2021, The E50K optineurin mutation impacts autophagy-mediated degradation of TDP-43 and leads to RGC apoptosis in vivo and in vitro, Cell Death Dis., 7, 49, 10.1038/s41420-021-00432-0 · DOI
- Tezel, 2006, Oxidative stress in glaucomatous neurodegeneration, mechanisms and consequences, Prog. Retin. Eye Res., 25, 490, 10.1016/j.preteyeres.2006.07.003 · DOI · Paper page
- Stroud, 2016, Accessory subunits are integral for assembly and function of human mitochondrial complex I, Nature, 538, 123, 10.1038/nature19754 · DOI · Paper page
- Wu, 2016, Structure of mammalian respiratory Supercomplex I1III2IV1, Cell, 167, 1598, 10.1016/j.cell.2016.11.012 · DOI · Paper page
- Chalasani, 2007, A glaucoma-associated mutant of optineurin selectively induces death of retinal ganglion cells which is inhibited by antioxidants, Invest. Ophthalmol. Vis. Sci., 48, 1607, 10.1167/iovs.06-0834 · DOI
- Hardie, 2012, AMPK, a nutrient and energy sensor that maintains energy homeostasis, Nat. Rev. Mol. Cell Biol., 13, 251, 10.1038/nrm3311 · DOI · Paper page
- Yu, 2018, Autophagy pathway, cellular and molecular mechanisms, Autophagy, 14, 207, 10.1080/15548627.2017.1378838 · DOI · Paper page
- Wong, 2018, Mitochondria-lysosome contacts regulate mitochondrial fission via RAB7 GTP hydrolysis, Nature, 554, 382, 10.1038/nature25486 · DOI · Paper page
- Audano, 2018, Mitochondria, lysosomes, and dysfunction, their meaning in neurodegeneration, J. Neurochem., 147, 291, 10.1111/jnc.14471 · DOI
- Abu-Remaileh, 2017, Lysosomal metabolomics reveals V-ATPase- and mTOR-dependent regulation of amino acid efflux from lysosomes, Science, 358, 807, 10.1126/science.aan6298 · DOI · Paper page
- Mauvezin, 2015, Autophagosome-lysosome fusion is independent of V-ATPase-mediated acidification, Nat. Commun., 6, 7007, 10.1038/ncomms8007 · DOI · Paper page
- Mangieri, 2014, ATP6V0C knockdown in neuroblastoma cells alters autophagy-lysosome pathway function and metabolism of proteins that accumulate in neurodegenerative disease, PLoS One, 9, 10.1371/journal.pone.0093257 · DOI
- London, 2013, The retina as a window to the brain-from eye research to CNS disorders, Nat. Rev. Neurol., 9, 44, 10.1038/nrneurol.2012.227 · DOI · Paper page
- Lee, 2019, Associations between recent and established ophthalmic conditions and risk of Alzheimer's disease, Alzheimers Dement., 15, 34, 10.1016/j.jalz.2018.06.2856 · DOI · Paper page
- Chiasseu, 2017, Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease, Mol. Neurodegener., 12, 58, 10.1186/s13024-017-0199-3 · DOI · Paper page
- Gupta, 2020, Retinal changes in Alzheimer's disease- integrated prospects of imaging, functional and molecular advances, Prog. Retin. Eye Res., 100899
- Hart, 2016, Ocular indicators of Alzheimer's, exploring disease in the retina, Acta Neuropathol., 132, 767, 10.1007/s00401-016-1613-6 · DOI · Paper page
- McKinnon, 2002, Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension, Invest. Ophthalmol. Vis. Sci., 43, 1077
- Lee, 2013, Tau degradation, the ubiquitin-proteasome system versus the autophagy-lysosome system, Prog. Neurobiol., 105, 49, 10.1016/j.pneurobio.2013.03.001 · DOI · Paper page
- Zhang, 2017, The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer's disease, Rev. Neurosci., 28, 861, 10.1515/revneuro-2017-0013 · DOI
- Iqbal, 2019, Alzheimer's disease is responsible for progressive age-dependent differential expression of various protein cascades in retina of mice, ACS Chem. Neurosci., 10, 2418, 10.1021/acschemneuro.8b00710 · DOI
- Fernandez-Nogales, 2016, Faulty splicing and cytoskeleton abnormalities in Huntington's disease, Brain Pathol., 26, 772, 10.1111/bpa.12430 · DOI · Paper page
- Raj, 2015, Alternative splicing in the mammalian nervous system, recent insights into mechanisms and functional roles, Neuron, 87, 14, 10.1016/j.neuron.2015.05.004 · DOI · Paper page
- Munemasa, 2009, The role of alpha A- and alpha B-crystallins in the survival of retinal ganglion cells after optic nerve axotomy, Invest. Ophthalmol. Vis. Sci., 50, 3869, 10.1167/iovs.08-3138 · DOI
- Piri, 2013, Crystallins in retinal ganglion cell survival and regeneration, Mol. Neurobiol., 48, 819, 10.1007/s12035-013-8470-2 · DOI
- Mirzaei, 2020, Retinal proteomics of experimental glaucoma model reveal intraocular pressure-induced mediators of neurodegenerative changes, J. Cell. Biochem., 121, 4931, 10.1002/jcb.29822 · DOI
- Shao, 2018, Young bone marrow Sca-1 cells protect aged retina from ischaemia-reperfusion injury through activation of FGF2, J. Cell Mol., 22, 6176, 10.1111/jcmm.13905 · DOI
- Huang, 2009, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nat. Protoc., 4, 44, 10.1038/nprot.2008.211 · DOI · Paper page
- Kramer, 2014, Causal analysis approaches in ingenuity pathway analysis, Bioinformatics, 30, 523, 10.1093/bioinformatics/btt703 · DOI · Paper page
Cited by
Huang, K.-C., Gomes, C., Shiga, Y., Belforte, N., VanderWall, K. B., Lavekar, S. S., Fligor, C. M., Harkin, J., Hetzer, S. M., Patil, S. V., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01872-2 · Cited by 19
Metadata
- Authors
- Liu, X., Wang, Q., Shao, Z., Zhang, S., Hou, M., Jiang, M., Du, M., Li, J., & Yuan, H.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-04-15
- Volume
- 30
- Issue
- 11
- Pages
- 1030-1044
- ISSN
- 0964-6906
- 1460-2083
- Cited by
- 25
- References
- 19
- Language
- en
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Funders
- National Natural Science Foundation of China (81870654, 82070956, 81970799)
- Applied Technology Research and Development Program of Heilongjiang Provincial Science and Technology Department (GA20C008)
- Heilongjiang Postdoctoral Scientific Research Developmental Fund (LBH-Q18082)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.